Adrienne Nicole Productions’ Post

Complex therapies, shortened product life cycles, and fragmented and incomplete data sources are making it harder for #biopharma companies to identify and reach all relevant prescribers. Check out this new ebook to learn: - 6 challenges of legacy data offerings that lead to missed opportunities with HCPs - 2 ways to segment your data to prioritize HCPs and understand the key messages and channels that resonate with them - 4 steps to building a connected engagement strategy to reach more prescribers in niche markets Read it here: https://bit.ly/3SIneMf #lifesciences #VeevaCompass

The rise of social media has transformed the healthcare landscape, offering new avenues for patient education, promotion, and personalised communication. Claude Waddington, our Commercial Strategist, shares insights on how increased social media use can benefit both patients and pharmaceutical GTM models.     Patients are actively sharing medication experiences on platforms like LinkedIn, TikTok, and HealthUnlocked. A survey by PatientsLikeMe reveals that 11% of Americans turn to social media for health information, and 9% use it to evaluate treatments. Social media content impacts 40% of patients' chronic condition management and physician choice, per Ogilvy's Influencer Trends report for 2023. For pharmaceutical companies, social media monitoring during product launches can shape KOL engagement strategies.     Platforms like LinkedIn and physician-only social media ecosystems can foster community building and provide real-world insights into medication effects. This approach, combined with user-generated and brand-generated content, improves customer engagement and product launches. Medical Affairs, Clinical Research, Marketing, and Market Access teams can leverage social enablement skills to strengthen relationships with KOLs, driving positive change by empowering patients, promoting collaboration, and fostering connections among stakeholders.    To learn more about our industry perspective, read the newsletter article: https://lnkd.in/dGpd-ZjB #KOLengagement #omnichannelmarketing #socialmedia #pharmaceuticals #ThePalindromic 

At the local and regional levels, social media platforms and professional networks, as well as messenger apps, are essential for pharmaceutical product launches. They facilitate community building, gather real-world insights on medication effects, and enable engagement with HCPs, KOLs, and patients (of course within the appropriate regulated context which changes from country to country). Platforms like LinkedIn, physician-only social media ecosystems, and messenger apps such as WhatsApp for Business, WeChat/WeCom and LINE embedded in CLM/Marketing workflows, foster collaboration, improve customer engagement, and strengthen relationships with stakeholders. Summary of perspective: a. Omni or multi-channel programs play a key role in successful pharmaceutical product launches. b. Social enablement skills that support stakeholder engagement are invaluable in this context. c. Effective content dissemination across various platforms significantly influences launch outcomes, particularly in rare disease and oncology areas. Thus, these skills are crucial for engaging stakeholders and achieving desired results. To learn more from others in the field, I would recommend engaging with Dr Namrata, Tim Russell, Christophe Jauquet, Julia Walsh, Kate Sears, David Douek, Rebecca Carter, Steven Xie, and Rajesh Kari to name a few. At The Palindromic, we have witnessed firsthand the profound impact of social engagement on disease awareness, KOL and DOL mapping, and brand insight generation. Through our team's decade-long journey leading projects in the pharma and medtech space, we have become ardent believers in the transformative power of social impact, shaping the future of healthcare and empowering patients, professionals, and communities alike. What are your thoughts? #socialmedia #pharma #medtech #socialenablement #KOLengagement

𝗧𝗵𝗶𝘀 𝗶𝘀 𝗮 𝗺𝘂𝘀𝘁-𝗿𝗲𝗮𝗱 𝗳𝗼𝗿 𝗮𝗻𝘆𝗼𝗻𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗯𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮 𝘀𝗽𝗮𝗰𝗲! With the rapid changes in the industry, staying ahead requires not just data, but the 𝙧𝙞𝙜𝙝𝙩 data. It's all about finding those key prescribers and connecting with them in meaningful ways. Thanks for sharing these valuable insights! Looking forward to diving into the strategies outlined in the ebook. 🚀 #BiopharmaInnovation #XPro

Improved DE&I in healthcare marketing strategies can reach diverse audiences more effectively and contribute to improved patient care outcomes.  Amanda Powers-Han, CMO of Greater Than One recently spoke with Pharma Executive about healthcare DE&I strategies including: 1) Challenges healthcare marketers face in crafting culturally sensitive messages that resonate with diverse audiences and address their specific healthcare needs 2) Other tactics that healthcare marketers can utilize to ensure their outreach goes beyond visuals to truly connect with diverse audiences on a deeper level All of this speaks to connecting companies with the right audience at the right time in the right way, which is something at which we excel.  We can help you tailor your outreach to diverse audiences and ensure your message is getting across without alienating your audience. Reach out to our media team at GreaterThanOne.com/contact.

❓ 𝐇𝐨𝐰 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐏𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧𝐚𝐥𝐬 (𝐇𝐂𝐏𝐬) 𝐨𝐧 𝐒𝐨𝐜𝐢𝐚𝐥 𝐌𝐞𝐝𝐢𝐚 In today's digital age, social media is a powerful tool for connecting with HCPs. Our blog explores: 🔍 The current state of HCPs on social media 📊 Key trends and statistics 💡 Best practices for effective engagement Discover how to leverage social media to influence and engage with HCPs, ensuring your pharma marketing strategies hit the mark. Don't miss out on these valuable insights! 👉 Link in the Comments #DigitalMarketing #Healthcare #PharmaMarketing #SocialMedia #HCPs #MarketingInsights #DigitalStrategy #AI #Pharmaceuticals #HealthcareProfessionals #VisualAbstract

If you believe GLP-1 agonists for #obesity treatment are just another class of #pharma products, you’re wrong. This market is unfolding like nothing we’ve seen in healthcare before. That means the strategies we’ve traditionally used to approach market access, brand marketing, corporate affairs and brand communications, medical affairs and everything else we do in #healthcare may not apply here.    Real Chemistry's first market-view report, titled “GLP-1 Agonists: Signals of a New Era,” underscores this reality… 💡 There’s a new “GLP-1 influencer” in town with online behaviors, content creation momentum and monetization approaches that mirror what has been seen with the beauty and fashion influencer community, rather than with healthcare influencers. This new phenomenon is putting additional strain on an already complex patient-healthcare provider relationship and creating pressure for marketing and communication teams to create new ways to engage, educate and activate.   💡 Growing consumer-led, online communities are joining forces to navigate and advise others on managing market impacts, such as shortages and access. As a result, these communities are circumventing the traditional ecosystem, creating gaps in real-world data visibility and adversely impacting the healthcare provider-patient relationship.   💡 Currently, there are 119 active GLP-1 agonist clinical trials, with 50+ in Phases 3 or 4. These trials cover more than 60 potential new disease states for GLP-1 treatment. The potential market entry of new drugs in five to 10 years means that organizations that are exploring launching new products will need stronger commercial readiness strategies to optimize their potential position with investors.   Leaders, brand planning season is upon us. How are you preparing for the impacts this market will have on your #business? Send me a message or comment here.    IRIS has the insights into what's happening now and the forces that could shape what's coming next: https://bit.ly/3wp8D0d. It’s time to see.    #glp1s #healthcareinsights #marketintelligence #research #brandstrategy #planning #realchemistry

As I shared earlier, in 2024 majority of pharmacos consider gaining deeper HCP insights one of their highest priorities as that will not only help elevate, but also drive their strategic HCP engagement. Yet their execution tactics is contrarian in ways. E.g. Focus on use of social channels to deliver scientific content by Pharmacos to HCPs is being reduced, knowing fully that a large proportion of HCP's (especially the younger HCPs)increasingly use social channels to consume scientific content. It is dichotomy such as this that begs a deeper & comprehensive review of their HCP activation efforts on the lines of: - Org design for HCP engagement & RACI - Content & interaction strategy & execution - Advanced analytics & business insights support needed for understanding the Competition, brand situation, disease and patient situation, payer activation and access - Definition & measurement of HCP engagement metrics targeted at continuous education, behaviour change and impact on clinical practice while staying compliant with the medico-legal & ethics requirements. #HCPActivation  #RepoftheFuture #CommercialExcellence

Brands need to ensure that diverse audiences feel seen and heard in their ads. This goes beyond visual representation and moves into connecting on a deeper level. Types of media utilized and media placement figure heavily into creating that connection and is something at which our media team excels.  In the Pharmaceutical Executive podcast below, Greater Than One's CMO, Amanda Powers-Han discusses: - How improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes - Challenges healthcare marketers face in crafting culturally sensitive messages that resonate with diverse audiences and address their specific healthcare needs - Other tactics healthcare marketers can utilize to connect with diverse audiences on a deeper level To talk to our media team about helping your brand team connect with diverse audiences contact them at GreaterThanOne.com/contact

💊 Tired of the pharma marketing maze? Our latest blog explores how explainer videos simplify science, keep it compliant, and cater to all audiences. Check it out now! https://lnkd.in/gp45i_Sy #pharmamarketing #explainervideos